FORDYCE MARSHALL (President and CEO) sold 7.9% of their position (18.50K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $679.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/13/2026ACC: 0001859453-26-000007
DirectorOfficer· President and CEO
Since May 2021
-18.50K
Net shares
Net seller
$679.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
18.50K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−14.22K
Price / share
$36.64
Trade value
$520.98K
% of position
6.0%
5/12/2026
235.24K→221.03K
Class A Common Stock
Direct
Shares
−4.28K
Price / share
$37.09
Trade value
$158.77K
% of position
1.9%
5/12/2026
221.03K→216.74K
Total
Net shares
−18.50K
Net value
-$679.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 5/12/2026 | S · Sale | −14.22K | $36.64 | $520.98K | 6.0% | 235.24K | 221.03K |
| Class A Common Stock Direct | 5/12/2026 | S · Sale | −4.28K | $37.09 | $158.77K | 1.9% | 221.03K | 216.74K |
| Total | −18.50K | -$679.75K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned122.95K
Class A Common Stock
IndirectShares owned99.08K
Total
222.03K indirect222.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 122.95K | Indirect |
| Class A Common Stock | 99.08K | Indirect |
| Total | 222.03K | 222.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported